Today: 30 June 2026
Browse Category

Health News 12 December 2025 - 24 January 2026

Why ImmunityBio stock is surging today: ANKTIVA sales jump and a key bladder-cancer trial nears the finish line

Why ImmunityBio stock is surging today: ANKTIVA sales jump and a key bladder-cancer trial nears the finish line

New York, Jan 16, 2026, 10:16 EST — Regular session ImmunityBio shares surged roughly 16.5% to $4.60 Friday morning, building on a strong rally after the biotech reported better-than-expected sales momentum for its main cancer drug. The company also detailed plans for a label-expansion effort. Trading volume exceeded 56 million shares, with the stock reaching an intraday peak of $5.20.
16 January 2026
···
Costco Canada recall expands: Peace by Chocolate pistachio chocolates pulled over salmonella risk

Costco Canada recall expands: Peace by Chocolate pistachio chocolates pulled over salmonella risk

Costco Wholesale Canada told customers who bought certain Peace by Chocolate gift boxes online to stop eating two pistachio-containing chocolates, after an ingredient supplier triggered a warning over possible Salmonella contamination. The “voluntary, precautionary” recall covers Our Classic Box – 15 assorted filled chocolates and The Harmony Bar included in Peace by Chocolate Small and Medium Bestsellers Boxes purchased on Costco.ca between Sept. 7 and Dec. 3, the notice showed. The warning lands as Canada’s pistachio recall list keeps growing, pulling in everything from plain nuts to snacks and sweets. In the past several months, more than 330 pistachio or pistachio-containing products have been recalled by the Canadian Food Inspection Agency, while the salmonella outbreak tied to the issue began in mid-March and has continued through January, CityNews reported.
9 January 2026
·
Merck (MRK) stock slips after-hours as CDC backs one-dose HPV shot; Cidara deal closes

Merck (MRK) stock slips after-hours as CDC backs one-dose HPV shot; Cidara deal closes

New York, Jan 7, 2026, 18:52 EST — After-hours Merck & Co shares edged down in after-hours trading on Wednesday after U.S. health officials updated the childhood immunization schedule and moved to a single dose for the human papillomavirus vaccine, a change that could pressure demand for Merck’s Gardasil shot. The stock was down about 0.2% at $108.60, after trading between $107.99 and $111.42 in the regular session. HHS.gov
8 January 2026
····
Merck stock dips after CDC vaccine overhaul puts Gardasil dosing in the spotlight

Merck stock dips after CDC vaccine overhaul puts Gardasil dosing in the spotlight

New York, January 5, 2026, 21:32 — Market closed Merck & Co shares dipped in late trading on Monday after U.S. health officials rewrote the childhood and adolescent immunization schedule, including a change to a one-dose recommendation for the human papillomavirus vaccine. Merck closed up 0.93% at $107.44 and was last down 0.22% at $107.20 after the bell. Yahoo Finance
6 January 2026
···
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

New York, January 5, 2026, 14:21 EST — Regular session Shares of Viking Therapeutics slid 9.9% to $31.93 in afternoon trading on Monday as obesity-drug stocks reacted to Novo Nordisk’s U.S. launch of a Wegovy weight-loss pill. Novo’s U.S.-listed shares rose 5.1%, while Eli Lilly fell 3.9% and the SPDR S&P Biotech ETF dropped 2.2%.
5 January 2026
·····
Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

New York, Jan 5, 2026, 13:31 EST — Regular session Arrowhead Pharmaceuticals shares were down about 6.9% on Monday after the company said Health Canada approved Redemplo, its triglyceride-lowering drug for familial chylomicronemia syndrome. The stock fell $4.68 to $63.11 after swinging between $60.75 and $70.87. MarketScreener
5 January 2026
···
Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Britain’s Tesco has recalled three 170-gram own-brand pate products after they were labelled with an incorrect use-by date, prompting a warning over a possible microbiological risk, the UK’s Food Standards Agency said on Jan. 3. The recall covers Tesco Coarse Farmhouse Pate, Coarse Ardennes Pate and Smooth Chicken Liver Pate with a use-by date of 05 January 2026. Food Standards Agency Use-by dates are safety deadlines for foods that spoil quickly, and the watchdog warns people should not eat food after that date even if it looks and smells normal. Mislabelled dates can leave shoppers relying on packaging that no longer reflects when the food is safe to eat. Food Standards Agency
4 January 2026
·
Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

Bupa UK on Wednesday renewed its role as Official Healthcare Partner of ParalympicsGB and agreed a new three-year contract between Bupa UK Insurance and Nuffield Health, the company said. The Nuffield agreement adds direct appointment booking and wider access to diagnostics for Bupa customers. The moves matter because speed to diagnosis is a selling point in private healthcare, where delays between referral, scans and treatment can drive customer frustration. Bupa is also tying its brand to elite sport at a time when sponsors are under pressure to show measurable health outcomes.
1 January 2026
Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

NEW YORK, December 31, 2025, 19:19 ET — After-hours Axsome Therapeutics, Inc. shares jumped 22.9% to $182.64 in after-hours trading on Wednesday after the company said the U.S. Food and Drug Administration accepted its supplemental New Drug Application for AXS-05 to treat agitation linked to Alzheimer’s disease and granted it Priority Review. The agency set an April 30, 2026 target action date, and CEO Herriot Tabuteau said “up to 76% of people with Alzheimer’s disease experience agitation.” GlobeNewswire
1 January 2026
···
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics Inc. is ending 2025 in the middle of one of biotech’s hottest battlegrounds: oral weight-loss medicines. As of Dec. 23, 2025, GPCR shares were trading around $67.50 in U.S. session data, after a volatile stretch driven by blockbuster obesity-trial headlines, a major equity financing, and a wave of analyst price-target updates. Below is a comprehensive roundup of the latest news, forecasts, and analysis available as of 23.12.2025, and what investors are watching next.
23 December 2025
····
FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

On December 22, 2025, Novo Nordisk won one of the most consequential regulatory decisions in modern obesity medicine: U.S. FDA approval of a once‑daily “Wegovy pill” for chronic weight management—marking the first oral GLP‑1 authorized in the U.S. specifically for weight loss. Novo Nordisk+1 For Novo Nordisk, the milestone is more than a product expansion. It’s a high‑stakes move to defend its GLP‑1 franchise, widen access beyond injections, and reassert momentum after a volatile year in which investors questioned its growth trajectory and competitive positioning. Reuters+1
23 December 2025
··
So Delicious Dairy Free Ice Cream Recall: Danone Pulls Salted Caramel Cluster Pints Over Possible “Small Stones” (Dec. 17, 2025)

So Delicious Dairy Free Ice Cream Recall: Danone Pulls Salted Caramel Cluster Pints Over Possible “Small Stones” (Dec. 17, 2025)

December 17, 2025 — If you keep dairy-free frozen treats stocked for the holidays, it’s worth taking a quick look in your freezer. Danone U.S. has issued a voluntary nationwide recall for specific pints of So Delicious Dairy Free Salted Caramel Cluster after the company warned the product may contain foreign materials — including small stones and other hard objects — in the cashew pieces mixed into the dessert. U.S. Food and Drug Administration+1 The recall, which was posted by the U.S. Food and Drug Administration as a company announcement, applies to a single So Delicious flavor and pint format. That matters for consumers who may have multiple So Delicious items at home: other So Delicious Dairy Free flavors and products are not included in this action. U.S. Food and Drug Administration+1
18 December 2025
·
California Vega Farms Egg Recall: 63 Sick, 13 Hospitalized in Salmonella Outbreak—How to Identify Affected Eggs

California Vega Farms Egg Recall: 63 Sick, 13 Hospitalized in Salmonella Outbreak—How to Identify Affected Eggs

SACRAMENTO, Calif. — A Salmonella Enteritidis outbreak in California has been linked to recalled Vega Farms in-shell brown eggs, with state health officials reporting 63 illnesses and 13 hospitalizations tied to the outbreak strain as of Dec. 5, according to the California Department of Public Health. California Department of Public Health The recall centers on eggs distributed in Northern California—primarily the Sacramento and Davis areas—and sold not only through retail outlets but also supplied to restaurants and farmers markets, officials said. California Department of Public Health+1
16 December 2025
Vega Farms Egg Recall Update: California Links Salmonella Outbreak to Dixon Farm Eggs; 63 Sick, 13 Hospitalized

Vega Farms Egg Recall Update: California Links Salmonella Outbreak to Dixon Farm Eggs; 63 Sick, 13 Hospitalized

SACRAMENTO, Calif. — California health officials are urging residents and businesses across parts of Northern California to stop eating, selling, or serving certain Vega Farms in-shell eggs after the products were linked to a Salmonella Enteritidis outbreak that has already sickened dozens of people. California Department of Public Health+1 The California Department of Public Health says that 63 California residents were reported ill as of Dec. 5, 2025, including 13 hospitalizations, with no deaths reported. The eggs were voluntarily recalled by Vega Farms, Inc. on Dec. 5, 2025, and the state has since released details to help consumers identify affected cartons and businesses remove any remaining stock. California Department of Public Health+2KCRA+2
13 December 2025
McCain Pizza Pockets Recall Australia 2025: Cheese & Bacon 400g Pulled from Woolworths, Coles and IGA After Plastic and Metal Contamination Warning

McCain Pizza Pockets Recall Australia 2025: Cheese & Bacon 400g Pulled from Woolworths, Coles and IGA After Plastic and Metal Contamination Warning

Australians are being urged to check their freezers after McCain Foods Pty Ltd issued a nationwide recall for McCain Cheese & Bacon Pizza Pockets following reports of foreign material in the product. The recall, published on Friday, 12 December 2025, covers items sold through major supermarkets and online deliveries across the country. Food Standards Australia New Zealand+1 The warning is straightforward: do not eat the affected pizza pockets. Food safety authorities say food products containing plastic and/or metal can cause illness or injury if consumed, and the product should be returned to the place of purchase for a full refund. Food Standards Australia New Zealand+1
12 December 2025
···
1 2 3 4

Stock Market Today

  • Rocket Lab Jumps After Striking $8 Billion Iridium Buyout
    June 29, 2026, 10:59 PM EDT. Rocket Lab Corp. (NASDAQ:RKLB) shot up 15.93% and ended at $98.01 after announcing an $8 billion takeover of Iridium Communications Inc. The combined cash and stock deal puts Iridium's value at $54 a share, 24% over its previous close. Rocket Lab says it's moving to create an integrated space business by adding Iridium's satellite network to its launch services. CEO Peter Beck said the plan is to use Iridium's infrastructure alongside Rocket Lab's production and launch capability to go after more markets and build out space applications. Deal completion is targeted for mid-2027, pending shareholder and regulatory sign-off. Rocket Lab's push into satellite communications comes as the sector keeps consolidating.
Go toTop